1418 related articles for article (PubMed ID: 18282509)
21. DNA demethylating agents and epigenetic therapy of cancer.
Mani S; Herceg Z
Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic opportunities and challenges in cancer.
Best JD; Carey N
Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050
[TBL] [Abstract][Full Text] [Related]
23. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
24. Targeting DNA methylation in cancer.
Szyf M
Bull Cancer; 2006 Sep; 93(9):961-72. PubMed ID: 16980240
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies.
Bhalla KN
J Clin Oncol; 2005 Jun; 23(17):3971-93. PubMed ID: 15897549
[TBL] [Abstract][Full Text] [Related]
26. [Targeting epigenetics plasticity as a novel target for human neoplasia].
Shinjo K; Kondo Y
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1654-8. PubMed ID: 20841927
[TBL] [Abstract][Full Text] [Related]
27. [Molecular mechanisms involved in epigenetic alterations in cancer].
Toyota M; Suzuki H; Nishizaka T; Sato A; Yamashita T
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1650-3. PubMed ID: 20841926
[TBL] [Abstract][Full Text] [Related]
28. Towards targeted epigenetic therapy of cancer.
Magic Z; Supic G; Brankovic-Magic M
J BUON; 2009 Sep; 14 Suppl 1():S79-88. PubMed ID: 19785074
[TBL] [Abstract][Full Text] [Related]
29. Dynamic and reversibility of heterochromatic gene silencing in human disease.
Zardo G; Fazi F; Travaglini L; Nervi C
Cell Res; 2005 Sep; 15(9):679-90. PubMed ID: 16212874
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic drivers and genetic passengers on the road to cancer.
Sawan C; Vaissière T; Murr R; Herceg Z
Mutat Res; 2008 Jul; 642(1-2):1-13. PubMed ID: 18471836
[TBL] [Abstract][Full Text] [Related]
31. Chromatin-remodelling mechanisms in cancer.
Lafon-Hughes L; Di Tomaso MV; Méndez-Acuña L; Martínez-López W
Mutat Res; 2008; 658(3):191-214. PubMed ID: 18403253
[TBL] [Abstract][Full Text] [Related]
32. The role of epigenetic alterations in pancreatic cancer.
Sato N; Goggins M
J Hepatobiliary Pancreat Surg; 2006; 13(4):286-95. PubMed ID: 16858539
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic changes in cancer.
Grønbaek K; Hother C; Jones PA
APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
[TBL] [Abstract][Full Text] [Related]
34. Histone acetylation and chromatin signature in stem cell identity and cancer.
Shukla V; Vaissière T; Herceg Z
Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
[TBL] [Abstract][Full Text] [Related]
37. The new frontier in cancer research: deciphering cancer epigenetics.
Lohrum M; Stunnenberg HG; Logie C
Int J Biochem Cell Biol; 2007; 39(7-8):1450-61. PubMed ID: 17442611
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic deregulation of DNA repair and its potential for therapy.
Hegi ME; Sciuscio D; Murat A; Levivier M; Stupp R
Clin Cancer Res; 2009 Aug; 15(16):5026-31. PubMed ID: 19671858
[TBL] [Abstract][Full Text] [Related]
39. Novel approaches on epigenetics.
Papait R; Monti E; Bonapace IM
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic changes in virus-associated human cancers.
Li HP; Leu YW; Chang YS
Cell Res; 2005 Apr; 15(4):262-71. PubMed ID: 15857581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
